JP2010526995A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526995A5
JP2010526995A5 JP2010506846A JP2010506846A JP2010526995A5 JP 2010526995 A5 JP2010526995 A5 JP 2010526995A5 JP 2010506846 A JP2010506846 A JP 2010506846A JP 2010506846 A JP2010506846 A JP 2010506846A JP 2010526995 A5 JP2010526995 A5 JP 2010526995A5
Authority
JP
Japan
Prior art keywords
colorectal cancer
timp
marker
hemoglobin
binding agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010506846A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526995A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/003642 external-priority patent/WO2008138522A1/en
Publication of JP2010526995A publication Critical patent/JP2010526995A/ja
Publication of JP2010526995A5 publication Critical patent/JP2010526995A5/ja
Withdrawn legal-status Critical Current

Links

JP2010506846A 2007-05-10 2008-05-07 結腸直腸癌のマーカーとしてのtimp−1の使用 Withdrawn JP2010526995A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07009396 2007-05-10
PCT/EP2008/003642 WO2008138522A1 (en) 2007-05-10 2008-05-07 Use of timp-1 as a marker for colorectal cancer

Publications (2)

Publication Number Publication Date
JP2010526995A JP2010526995A (ja) 2010-08-05
JP2010526995A5 true JP2010526995A5 (https=) 2011-02-17

Family

ID=38521224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506846A Withdrawn JP2010526995A (ja) 2007-05-10 2008-05-07 結腸直腸癌のマーカーとしてのtimp−1の使用

Country Status (6)

Country Link
US (1) US20100159479A1 (https=)
EP (1) EP2145190A1 (https=)
JP (1) JP2010526995A (https=)
CN (1) CN101680898A (https=)
CA (1) CA2684024A1 (https=)
WO (1) WO2008138522A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE521894T1 (de) * 2007-11-20 2011-09-15 Hoffmann La Roche Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
EP2239577A1 (en) * 2009-04-07 2010-10-13 Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
CN103140760B (zh) 2010-07-14 2016-01-27 联邦科学与工业研究组织 结肠直肠癌的诊断
CN104178562B (zh) * 2013-05-21 2018-11-09 生物梅里埃股份公司 一种大肠癌预后试剂盒
EP3073268A1 (en) * 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
CN105891372B (zh) * 2016-06-12 2018-11-02 上海阿趣生物科技有限公司 原发性肝癌伴胆管癌栓生物标志物及其用途
CN113122544A (zh) * 2021-04-25 2021-07-16 杭州广科安德生物科技有限公司 一种特异性结合timp1蛋白的核酸适配体及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324636A (en) * 1991-07-24 1994-06-28 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Radiorespirometer and method of use
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system
JP2000510949A (ja) * 1996-04-26 2000-08-22 チルドレンズ メディカル センター コーポレーション 組織のリモデリングに関連した状態のための非観血的酵素スクリーン
US7374886B2 (en) * 1999-04-09 2008-05-20 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
NZ515311A (en) * 1999-04-09 2002-11-26 Rigshospitalet Mass screening and highly specific early identification of colorectal or metastatic breast cancer by measuring TIMP-1 tissue inhibitor
WO2002031507A2 (en) * 2000-10-13 2002-04-18 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
WO2005095978A1 (en) * 2004-03-30 2005-10-13 Roche Diagnostics Gmbh Pyrroline-5-carboxylate reductase as a marker for colorectal concer
FR2919065B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.

Similar Documents

Publication Publication Date Title
JP2009537798A5 (https=)
JP2014508298A5 (https=)
JP2010526995A5 (https=)
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
JP2009538607A5 (https=)
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
WO2008021290A8 (en) Organ-specific proteins and methods of their use
JP2006517093A5 (https=)
JP2017524130A5 (https=)
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
WO2010083252A3 (en) Ratio based biomarkers and methods of use thereof
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
MY162697A (en) Methods, devices and kits for detecting or monitoring acute kidney injury
JP2012073260A5 (https=)
IL181131A0 (en) USE OF C3a AND DERIVATIVES THEREOF AS A BIOMARKER FOR COLORECTAL ADEMONA AND/OR CARCINOMA; DIAGNOSIS METHOD AND TEST SYSTEM USING THE SAME
JP2012509477A5 (https=)
WO2012017466A8 (en) Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
WO2009054475A1 (ja) 癌の検出方法
WO2012032345A3 (en) Biomarker signatures and uses thereof
ATE466108T1 (de) Optoelektronisches detektionssystem
JP2016536568A5 (https=)
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
MX2010004335A (es) Metodo y sistema para la deteccion de un tipo seleccionado de moleculas en una muestra.